Revance Therapeutics shares owned by Us Bancorp
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Us Bancorp
from 13F filings
Historical chart of Us Bancorp investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Us Bancorp
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $10k | 1.9k | 5.19 |
| 2024-06-30 | $4.5k | 1.8k | 2.57 |
| 2024-03-31 | $15k | 3.0k | 4.92 |
| 2023-12-31 | $21k | 2.4k | 8.79 |
| 2023-09-30 | $38k | 3.3k | 11.47 |
| 2023-06-30 | $81k | 3.2k | 25.31 |
| 2023-03-31 | $128k | 4.0k | 32.21 |
| 2022-12-31 | $487k | 26k | 18.46 |
| 2022-09-30 | $458k | 17k | 26.96 |
| 2022-06-30 | $12k | 852 | 14.08 |
| 2022-03-31 | $41k | 2.1k | 19.47 |
| 2021-12-31 | $41k | 2.5k | 16.20 |
| 2021-09-30 | $8.0k | 275 | 29.09 |
| 2021-06-30 | $8.0k | 275 | 29.09 |
| 2021-03-31 | $8.0k | 275 | 29.09 |
| 2020-12-31 | $7.0k | 257 | 27.24 |
| 2020-09-30 | $6.0k | 257 | 23.35 |
| 2020-06-30 | $6.0k | 257 | 23.35 |
| 2020-03-31 | $3.0k | 198 | 15.15 |
| 2019-12-31 | $3.0k | 198 | 15.15 |
| 2019-09-30 | $11k | 743 | 15.15 |
| 2019-06-30 | $7.0k | 545 | 12.84 |
| 2019-03-31 | $12k | 673 | 17.34 |
| 2018-12-31 | $10k | 500 | 20.00 |
| 2018-09-30 | $19k | 760 | 25.00 |
| 2018-06-30 | $21k | 760 | 27.63 |
| 2018-03-31 | $15k | 500 | 30.00 |